Helen McShane

Helen McShane

University of Oxford

H-index: 72

Europe-United Kingdom

About Helen McShane

Helen McShane, With an exceptional h-index of 72 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of TB vaccines, immunology, HIV.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development and application of the direct mycobacterial growth inhibition assay: a systematic review

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 …

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a …

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open …

Revaccination with BCG: does it work?

Long COVID research: an update from the PHOSP-COVID Scientific Summit

Helen McShane Information

University

Position

The Jenner Institute

Citations(all)

18705

Citations(since 2020)

7706

Cited By

13206

hIndex(all)

72

hIndex(since 2020)

43

i10Index(all)

180

i10Index(since 2020)

150

Email

University Profile Page

Google Scholar

Helen McShane Skills & Research Interests

TB vaccines

immunology

HIV

Top articles of Helen McShane

Title

Journal

Author(s)

Publication Date

Development and application of the direct mycobacterial growth inhibition assay: a systematic review

Hannah Painter

Eli Harriss

Helen A Fletcher

Helen McShane

Rachel Tanner

2024/2/6

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 …

The Lancet Microbe

Susan Jackson

Julia L Marshall

Andrew Mawer

Raquel Lopez-Ramon

Stephanie A Harris

...

2024/5/1

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

The Lancet Infectious Diseases

Anne Wajja

Beatrice Nassanga

Agnes Natukunda

Joel Serubanja

Josephine Tumusiime

...

2024/2/1

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a …

The Lancet Infectious Diseases

Iman Satti

Julia L Marshall

Stephanie A Harris

Rachel Wittenberg

Rachel Tanner

...

2024/4/12

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment

Proceedings of the National Academy of Sciences

Jingyi Ma

Khatoun Al Moussawi

Hantao Lou

Hok Fung Chan

Yihua Wang

...

2024/3/5

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open …

The Lancet Infectious Diseases

Anne Wajja

Beatrice Nassanga

Agnes Natukunda

Joel Serubanja

Josephine Tumusiime

...

2024/3/1

Revaccination with BCG: does it work?

The Lancet Infectious Diseases

Helen McShane

2024/2/26

Long COVID research: an update from the PHOSP-COVID Scientific Summit

The Lancet Respiratory Medicine

Christopher E Brightling

Rachael A Evans

Amisha Singapuri

Nikki Smith

Louise V Wain

...

2023/11/1

Injection fears and COVID-19 vaccine hesitancy

Psychological medicine

Daniel Freeman

Sinéad Lambe

Ly-Mee Yu

Jason Freeman

Andrew Chadwick

...

2023/3

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

The Lancet Respiratory Medicine

Callum Jackson

Iain D Stewart

Tatiana Plekhanova

Peter S Cunningham

Andrew L Hazel

...

2023/8/1

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

The Lancet Respiratory Medicine

Betty Raman

Celeste McCracken

Mark P Cassar

Alastair J Moss

Lucy Finnigan

...

2023/11/1

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

EClinicalMedicine

Hamish JC McAuley

Rachael A Evans

Charlotte E Bolton

Christopher E Brightling

James D Chalmers

...

2023/3/1

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

The Lancet Regional Health–Europe

Bang Zheng

Giulia Vivaldi

Luke Daines

Olivia C Leavy

Matthew Richardson

...

2023/6/1

Improving tuberculosis vaccine trial efficiency: a tough nut to crack

Helen McShane

2023/11/1

Exploring the ethics of tuberculosis human challenge models

Journal of Medical Ethics

Abie Rohrig

Josh Morrison

Gavriel Kleinwaks

Jonathan Pugh

Helen McShane

...

2023/12/30

Evaluation of 1st WHO Anti-Malaria Reference Reagent for Competitive ELISA Harmonisation and Development of ADAMSEL Analytical Platform

medRxiv

Bhagwati Khatri

Peggy Riese

Hanna Shkarlet

Daniella Mortier

Helen McShane

...

2023

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

Hazel Morrison

Susan Jackson

Helen McShane

2023/5/25

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge

Frontiers in Immunology

Elena Stylianou

Nawamin Pinpathomrat

Oliver Sampson

Alexandre Richard

Marcellus Korompis

...

2023/10/5

Identification of overlapping MHC-bound peptides presented by Mycobacterium tuberculosis and Mycobacterium bovis BCG infected cells using immunopeptidomics

18th International Congress of Immunology

Paulo JG Bettencourt

Salem Almujri

Annalisa Nicastri

Rachel Tanner

Elena Stylianou

...

2023/12/1

Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop …

Stephen B Gordon

Simon Sichone

Anthony E Chirwa

Phoebe Hazenberg

Zacharia Kafuko

...

2023

See List of Professors in Helen McShane University(University of Oxford)